Travis Mickle
Vorsitzender bei KemPharm Denmark A/S
Vermögen: 261 418 $ am 31.05.2024
Aktive Positionen von Travis Mickle
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
KemPharm Denmark A/S
 KemPharm Denmark A/S Miscellaneous Commercial ServicesCommercial Services Part of Zevra Therapeutics, Inc., KemPharm Denmark A/S is a Danish company that engages in the development of novel treatments for central nervous system. The company is based in Copenhagen, Denmark. The company was founded in 2022. The CEO is Raymond la Duane Clifton. | Vorsitzender | 13.05.2022 | - |
Karriereverlauf von Travis Mickle
Ehemalige bekannte Positionen von Travis Mickle
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ZEVRA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 05.11.2021 | 25.04.2023 |
| Vorstandsvorsitzender | 01.10.2010 | 25.04.2023 | |
| Vorsitzender | 01.11.2014 | 05.11.2021 | |
| Technik-/Wissenschafts-/F&E-Leiter | 30.10.2006 | 01.10.2010 | |
| Gründer | 30.10.2006 | 25.04.2023 | |
| Präsident | 30.10.2006 | 25.04.2023 | |
New River Pharmaceuticals, Inc.
 New River Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New River Pharmaceuticals, Inc. develops pharmaceutical products. Its product candidates in clinical development are an amphetamine derivative (NDA filed) and an opioid derivative that they believe will provide alternatives to marketed drugs. The company was founded by Randal J. Kirk in 1996 and is headquartered in Radford, VA. | Corporate Officer/Principal | 01.01.2002 | 01.10.2005 |
Ausbildung von Travis Mickle
| Simpson College | Undergraduate Degree |
| University of Iowa | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
| Dänemark | 2 |
Operativ
| Chairman | 2 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ZEVRA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
New River Pharmaceuticals, Inc.
New River Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New River Pharmaceuticals, Inc. develops pharmaceutical products. Its product candidates in clinical development are an amphetamine derivative (NDA filed) and an opioid derivative that they believe will provide alternatives to marketed drugs. The company was founded by Randal J. Kirk in 1996 and is headquartered in Radford, VA. | Health Technology |
KemPharm Denmark A/S
KemPharm Denmark A/S Miscellaneous Commercial ServicesCommercial Services Part of Zevra Therapeutics, Inc., KemPharm Denmark A/S is a Danish company that engages in the development of novel treatments for central nervous system. The company is based in Copenhagen, Denmark. The company was founded in 2022. The CEO is Raymond la Duane Clifton. | Commercial Services |
- Börse
- Insiders
- Travis Mickle
- Erfahrung